Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
You have these already downloaded
We have sent you a copy of the report to your email again.
QIAGEN is a global leader in delivering best-in-class samples to insight solutions to more than 500,000 customers worldwide.
The company has steadily fueled business growth and expanded its global footprint through consistent M&As across geographies.
As a long-term strategic partner, TCS played an instrumental role in helping QIAGEN integrate and merge with other organizations seamlessly, by leveraging TCS’ presence in the region with onsite personnel and resources.
Together, TCS and QIAGEN co-innovated and explored over 150 innovative ideas and digitized key IT and business processes, that helped reimagine and optimize IT service delivery. This brought QIAGEN’s IT infrastructure closer to its 4,700 employees across 35 countries.
Driven by the success of the initial engagement, QIAGEN decided to entrust TCS’ security operations center with the task of protecting its global asset network against both internal and external threats, 24x7.
As a result of the positive outcomes, QIAGEN relies on TCS as a strategic partner and is planning to extend the service contract for five more years. In addition to IT services, TCS continues to provide non-IT services in other areas, such as research and development (R&D), human resources, finance, legal, and the like.
While reflecting on how well the TCS-QIAGEN collaboration has shaped up over the last few years, Jonathan mentions that it has been an amazing journey, and it is difficult to continue differentiating between the two partners.
TCS’ extensive domain knowledge has been critical for bringing value to the business and ensuring that the 500,000 customers of QIAGEN experience the best that the company has to offer.
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
QIAGEN-TCS 10-year Partnership Accelerates Digital Transformation
Reimagining Pharma Labeling with New-Age Technologies
TCS Life Sciences Forum: Unlocking the Power of AI and Generative AI
EU MDR deadline extension: Making medtech manufacturers future-ready
Integrated ecosystems are key to better patient outcomes.
Talk to our experts